The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.75 billion in 2025 to $2.99 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, expansion of pain management therapies, growth in movement disorder treatments, rising acceptance of implantable medical devices, advancements in neurostimulation technology.
The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising investments in neurotechnology research, expansion of minimally invasive implantation techniques, growing adoption of smart implantable devices, increasing focus on chronic disease management. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of rechargeable stimulators, growing integration of adaptive stimulation technologies, expansion of multi-indication neuromodulation applications, enhanced focus on long-term device performance.
The rising incidence of neurological diseases is anticipated to drive growth in the internal neuromodulation devices market. Neurological diseases encompass a wide range of disorders that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices are used to treat neurological and psychiatric conditions by delivering targeted electrical stimulation to specific parts of the nervous system, helping to alleviate symptoms like chronic pain, movement disorders, and mood disorders. These devices can enhance patients' quality of life by reducing symptoms, making it easier for them to carry out daily tasks. For example, in April 2023, the National Library of Medicine, a U.S.-based biomedical library, reported that 6.7 million Americans are living with Alzheimer’s, a number projected to reach 13.8 million by 2060. Consequently, the increasing prevalence of neurological diseases is fueling the expansion of the internal neuromodulation devices market.
Major companies operating in the internal neuromodulation devices market are emphasizing the development of advanced digital health solutions, including remote-care platforms, to support continuous therapy management, limit the need for in-person clinical visits, and improve patient safety. In neuromodulation, remote-care platforms are digital systems that enable clinicians to remotely monitor device functionality, evaluate patient status, and modify therapy parameters in real time through connected applications. For instance, in April 2023, Biotronik SE & Co. KG, a Germany-based medical technology company headquartered in Berlin, received U.S. FDA approval for its Prospera™ spinal cord stimulation (SCS) system, which integrates Embrace One™, a next-generation remote-care model. This platform provides automatic, objective, daily remote monitoring and continuous therapy oversight. Designed to support proactive and responsive care, it allows clinicians to identify issues earlier, remotely adjust therapy settings, and reduce the frequency of in-person evaluations. According to Biotronik, Embrace One™ enables proactive care by delivering ongoing remote monitoring, management, and support, strengthening clinical decision-making and long-term patient outcomes.
In April 2025, Globus Medical, Inc., a Pennsylvania, USA-based publicly traded musculoskeletal solutions company acquired Nevro Corp. for an undisclosed amount. With this acquisition, Globus Medical aims to expand into new markets for future growth, accelerate the market penetration of Nevro’s differentiated high-frequency spinal cord stimulation technology, and bring much-needed and clinically superior relief to patients suffering from chronic pain, while creating long-term value and enhanced profitability through operational capabilities and global infrastructure Nevro Corp. is a US-based provider of internal neuromodulation devices.
Major companies operating in the internal neuromodulation devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, LivaNova plc, Nevro Corp., Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, NeuroPace Inc., Aleva Neurotherapeutics SA, EnteroMedics Inc., EndoStim Inc., MicroTransponder Inc., BioControl Medical Ltd., Synapse Biomedical Inc., Neuros Medical Inc., Stimwave Technologies Incorporated, Nuvectra Corporation, Uroplasty Inc., Second Sight Medical Products Inc., NeuroMetrix Inc.
North America was the largest region in the internal neuromodulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the internal neuromodulation devices market by increasing costs of imported electronic components, implantable batteries, precision electrodes, and medical-grade biomaterials. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-value devices, while Asia-Pacific faces higher manufacturing input costs. These tariffs are elevating device prices and affecting reimbursement dynamics. However, they are also promoting domestic device manufacturing, local assembly of components, and regional innovation in neuromodulation technologies.
The internal neuromodulation devices market research report is one of a series of new reports that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.
The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.
The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising investments in neurotechnology research, expansion of minimally invasive implantation techniques, growing adoption of smart implantable devices, increasing focus on chronic disease management. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of rechargeable stimulators, growing integration of adaptive stimulation technologies, expansion of multi-indication neuromodulation applications, enhanced focus on long-term device performance.
The rising incidence of neurological diseases is anticipated to drive growth in the internal neuromodulation devices market. Neurological diseases encompass a wide range of disorders that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices are used to treat neurological and psychiatric conditions by delivering targeted electrical stimulation to specific parts of the nervous system, helping to alleviate symptoms like chronic pain, movement disorders, and mood disorders. These devices can enhance patients' quality of life by reducing symptoms, making it easier for them to carry out daily tasks. For example, in April 2023, the National Library of Medicine, a U.S.-based biomedical library, reported that 6.7 million Americans are living with Alzheimer’s, a number projected to reach 13.8 million by 2060. Consequently, the increasing prevalence of neurological diseases is fueling the expansion of the internal neuromodulation devices market.
Major companies operating in the internal neuromodulation devices market are emphasizing the development of advanced digital health solutions, including remote-care platforms, to support continuous therapy management, limit the need for in-person clinical visits, and improve patient safety. In neuromodulation, remote-care platforms are digital systems that enable clinicians to remotely monitor device functionality, evaluate patient status, and modify therapy parameters in real time through connected applications. For instance, in April 2023, Biotronik SE & Co. KG, a Germany-based medical technology company headquartered in Berlin, received U.S. FDA approval for its Prospera™ spinal cord stimulation (SCS) system, which integrates Embrace One™, a next-generation remote-care model. This platform provides automatic, objective, daily remote monitoring and continuous therapy oversight. Designed to support proactive and responsive care, it allows clinicians to identify issues earlier, remotely adjust therapy settings, and reduce the frequency of in-person evaluations. According to Biotronik, Embrace One™ enables proactive care by delivering ongoing remote monitoring, management, and support, strengthening clinical decision-making and long-term patient outcomes.
In April 2025, Globus Medical, Inc., a Pennsylvania, USA-based publicly traded musculoskeletal solutions company acquired Nevro Corp. for an undisclosed amount. With this acquisition, Globus Medical aims to expand into new markets for future growth, accelerate the market penetration of Nevro’s differentiated high-frequency spinal cord stimulation technology, and bring much-needed and clinically superior relief to patients suffering from chronic pain, while creating long-term value and enhanced profitability through operational capabilities and global infrastructure Nevro Corp. is a US-based provider of internal neuromodulation devices.
Major companies operating in the internal neuromodulation devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, LivaNova plc, Nevro Corp., Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, NeuroPace Inc., Aleva Neurotherapeutics SA, EnteroMedics Inc., EndoStim Inc., MicroTransponder Inc., BioControl Medical Ltd., Synapse Biomedical Inc., Neuros Medical Inc., Stimwave Technologies Incorporated, Nuvectra Corporation, Uroplasty Inc., Second Sight Medical Products Inc., NeuroMetrix Inc.
North America was the largest region in the internal neuromodulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the internal neuromodulation devices market by increasing costs of imported electronic components, implantable batteries, precision electrodes, and medical-grade biomaterials. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-value devices, while Asia-Pacific faces higher manufacturing input costs. These tariffs are elevating device prices and affecting reimbursement dynamics. However, they are also promoting domestic device manufacturing, local assembly of components, and regional innovation in neuromodulation technologies.
The internal neuromodulation devices market research report is one of a series of new reports that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.
The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.
The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Internal Neuromodulation Devices Market Characteristics
3. Internal Neuromodulation Devices Market Supply Chain Analysis
4. Global Internal Neuromodulation Devices Market Trends and Strategies
5. Internal Neuromodulation Devices Market Analysis of End Use Industries
7. Global Internal Neuromodulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Internal Neuromodulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Internal Neuromodulation Devices Market Segmentation
10. Internal Neuromodulation Devices Market Regional and Country Analysis
11. Asia-Pacific Internal Neuromodulation Devices Market
12. China Internal Neuromodulation Devices Market
13. India Internal Neuromodulation Devices Market
14. Japan Internal Neuromodulation Devices Market
15. Australia Internal Neuromodulation Devices Market
16. Indonesia Internal Neuromodulation Devices Market
17. South Korea Internal Neuromodulation Devices Market
18. Taiwan Internal Neuromodulation Devices Market
19. South East Asia Internal Neuromodulation Devices Market
20. Western Europe Internal Neuromodulation Devices Market
21. UK Internal Neuromodulation Devices Market
22. Germany Internal Neuromodulation Devices Market
23. France Internal Neuromodulation Devices Market
24. Italy Internal Neuromodulation Devices Market
25. Spain Internal Neuromodulation Devices Market
26. Eastern Europe Internal Neuromodulation Devices Market
27. Russia Internal Neuromodulation Devices Market
28. North America Internal Neuromodulation Devices Market
29. USA Internal Neuromodulation Devices Market
30. Canada Internal Neuromodulation Devices Market
31. South America Internal Neuromodulation Devices Market
32. Brazil Internal Neuromodulation Devices Market
33. Middle East Internal Neuromodulation Devices Market
34. Africa Internal Neuromodulation Devices Market
36. Internal Neuromodulation Devices Market Competitive Landscape and Company Profiles
37. Internal Neuromodulation Devices Market Other Major and Innovative Companies
40. Internal Neuromodulation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Internal Neuromodulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for internal neuromodulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The internal neuromodulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator2) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
3) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
4) By End-User: Hospitals; Clinics
Subsegments:
1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator; Rechargeable Spinal Cord Stimulator; Non-Rechargeable Spinal Cord Stimulator2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator; Dual Lead Deep Brain Stimulator; Adaptive Deep Brain Stimulator
3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator; Rechargeable Implantable Sacral Nerve Stimulators; Non-Rechargeable Implantable Sacral Nerve Stimulators
4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator; Closed-Loop Implantable Vagus Nerve Stimulators
5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator; Programmable Gastric Neuro Stimulators
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; LivaNova plc; Nevro Corp.; Axonics Modulation Technologies Inc.; Saluda Medical Pty Limited; NeuroPace Inc.; Aleva Neurotherapeutics SA; EnteroMedics Inc.; EndoStim Inc.; MicroTransponder Inc.; BioControl Medical Ltd.; Synapse Biomedical Inc.; Neuros Medical Inc.; Stimwave Technologies Incorporated; Nuvectra Corporation; Uroplasty Inc.; Second Sight Medical Products Inc.; NeuroMetrix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Internal Neuromodulation Devices market report include:- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- LivaNova plc
- Nevro Corp.
- Axonics Modulation Technologies Inc.
- Saluda Medical Pty Limited
- NeuroPace Inc.
- Aleva Neurotherapeutics SA
- EnteroMedics Inc.
- EndoStim Inc.
- MicroTransponder Inc.
- BioControl Medical Ltd.
- Synapse Biomedical Inc.
- Neuros Medical Inc.
- Stimwave Technologies Incorporated
- Nuvectra Corporation
- Uroplasty Inc.
- Second Sight Medical Products Inc.
- NeuroMetrix Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.99 Billion |
| Forecasted Market Value ( USD | $ 4.24 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
